KannaLife Sciences, Inc. (“KannaLife”), is a bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer (“NIH-OTT”)
for the Commercialization of U.S. Patent #6630507, “Cannabinoids as Antioxidants and Neuroprotectants”
(the “‘507 Patent”). KannaLife is currently conducting research and development at the Bucks County Pennsylvania Biotechnology Center
in Doylestown, PA, for a target drug candidate to treat Hepatic Encephalopathy (“HE”) and Chronic Traumatic Encephalopathy (“CTE”). HE and CTE are both oxidative stress related diseases that affects the cognitive and behavioral functions, and the wellness of the brain.
We were created to develop natural, phyto-medical products to be used in health and wellness regimens. We are also involved in the research and development of novel new therapeutic agents to be used as transport carriers for other compounds seeking to break the blood/brain barrier as well as our own compounds to be used for the treatment and prevention of oxidative and neuro-toxic stresses born from a variety of ailments and illnesses.
KannaLife’s unique approach to drug development combines traditional healthcare practices utilizing natural medicine with western technology to create its pipeline of potential drug candidates for clinical development. Traditional healthcare dates back over 5,000 years, and, according to the World Health Organization, is the primary source of preventative medicine in approximately 80% of the world today.
The scientific team, comprised of dedicated professionals, clinicians and bio-chemists, all have a strong background in phyto-pharmaceutical, biological and Ayurvedic sciences with a long track record of successfully developing drugs from plant sources that are complex in nature and structure. The team also has the requisite relationships with nationally supported institutions of health as well as top academic food and science departments at several recognized universities in the United States.
KannaLife depends on the sustainability of plant life to create its products and practices environmentally sound business practices.
Our ultimate goal is to become a profitable and socially responsible company that seeks to improve the quality of life of patients needing and using our products.